ARE Luciferase Reporter HepG2 Cell Line (Nrf2 Antioxidant Pathway)

Catalog #
60513
$2,570 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The antioxidant response element (ARE) Luciferase Reporter HepG2 hepatic cell line contains a stably integrated firefly luciferase reporter under the control of ARE, which is recognized by the transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2). Luciferase expression correlates with activation of Nrf2 and the antioxidant pathway. This cell line was validated by stimulation with tert-butylhydroquinone, sulforaphane, and RTA-408 (omaveloxone).

 

Figure 1: Illustration of the ARE Luciferase Reporter HepG2 Cell Line (Nrf2 Antioxidant Pathway) mechanism.

Interested in screening and profiling inhibitors or activators of the Nrf2 signaling pathway without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

This product has been cited 44 times.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
ARE cell line, Nrf2 reporter, Nrf, Hepg2, ARE
Product Info
Storage and Usage
Citations44
Host Cell Line
HepG2, Human hepatocellular carcinoma, epithelial-like cells, adherent
Supplied As
Each vial contains >1 x 106 cells in 1 ml of Cell Freezing Medium (BPS Bioscience #79796)
Materials Required But Not Supplied

Media Required for Cell Culture

Name  Ordering Information
Thaw Medium 1 BPS Bioscience #60187
Growth Medium 1k BPS Bioscience #79533

 

Materials Used in the Cellular Assay

Name Orderinig Information
Tert-butylhydroquinone Signma #112941
DL-Sulforaphane Sigma #S4441
RTA-408 (Omaveloxolone) MedChemExpress #HY-12212
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
White clear-bottom 96-well cell culture plate  
Luminometer  
UniProt #
Q16236
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

Nrf2 is a transcription factor activated in response to toxic and oxidative drugs and chemicals. Under normal conditions, Nrf2 is retained in the cytosol through its binding to the cytoskeletal protein Kelch-like ECH-associated protein 1 (Keap1). Nrf2 is released from Keap1 upon oxidative stress and translocates to the nucleus, where it binds to the ARE promoter region of genes involved in the oxidative stress response and in drug detoxification, including genes encoding antioxidant enzymes that protect the cell from oxidative damage. Nrf2 supports cellular resistance to carcinogens and to inflammation, and dysfunction can lead to neurological diseases such as Alzheimer disease, Parkinson’s and Huntington’s diseases and amyotrophic lateral sclerosis (AMS). Its function is particularly important in the liver, where it contributes to protection against viral hepatitis and alcoholic and nonalcoholic liver disease. Molecules able to interact with Nrf2 and enhance is protective role are of great interest in medicine.

References

Cuadrado A, et al. 2019 Nature Rev. Drug Discovery, 18: 295-317.
Zgorzynska E., et al., 2021 Int J Mol Sci, 22(17): 9592.